Thomas A Prohaska Selected Research

Thomas A Prohaska Research Topics

3	Hypertriglyceridemia 04/2024 - 05/2023
3	Atherosclerosis 01/2022 - 07/2015
2	Pancreatitis 04/2024 - 02/2024
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 04/2024 - 05/2023
2	Inflammation (Inflammations) 01/2018 - 04/2016
1	Costello Syndrome 05/2023
1	Familial Partial Lipodystrophy (Dunnigan Syndrome) 05/2023
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Obesity 04/2016
1	Insulin Resistance 04/2016
1	Glucose Intolerance 04/2016
1	Arthrogryposis renal dysfunction cholestasis syndrome 02/2015
1	ST Elevation Myocardial Infarction 02/2015
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 02/2015
1	Neoplasms (Cancer) 01/2012

4	EpitopesIBA 01/2022 - 02/2015
4	Immunoglobulin M (IgM)IBA 01/2022 - 02/2015
3	Triglycerides (Triacylglycerol)IBA 04/2024 - 05/2023
3	AntibodiesIBA 04/2016 - 02/2015
2	Apolipoprotein C-IIIIBA 04/2024 - 05/2023
2	ISIS 304801IBA 02/2024 - 05/2023
2	Apolipoproteins E (ApoE)IBA 01/2018 - 07/2015
1	HDL CholesterolIBA 04/2024
1	ApolipoproteinsIBA 04/2024
1	Antisense OligonucleotidesIBA 05/2023
1	Messenger RNA (mRNA)IBA 05/2023
1	Single-Chain AntibodiesIBA 01/2018
1	1-penicillamyl-Leu(2)- oxytocinIBA 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	CholesterolIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 04/2016
1	AntigensIBA 07/2015
1	Interleukin-8 (Interleukin 8)IBA 02/2015
1	oxidized low density lipoproteinIBA 02/2015
1	Monoclonal AntibodiesIBA 02/2015
1	TrypsinogenIBA 01/2012

2	Therapeutics 04/2024 - 01/2018